Cargando…
cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment.
A study on the in vitro sensitivity of tumour cells from patients with ovarian cancer has been carried out in parallel with a clinical study designed to evaluate the role of high-dose cis-platinum (CIS) as first-line chemotherapy. A total of 50 samples from 102 patients have been successfully cultur...
Autores principales: | Wilson, A. P., Ford, C. H., Newman, C. E., Howell, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002397/ https://www.ncbi.nlm.nih.gov/pubmed/3435704 |
Ejemplares similares
-
cis-Dichloridobis(triisopropoxyphosphine)platinum(II)
por: Slawin, Alexandra M. Z., et al.
Publicado: (2009) -
Cis dichlorodiammine platinum induced DNA interstrand cross-links in primary cultures of human ovarian cancer.
por: Balconi, G., et al.
Publicado: (1991) -
Enhancement of cytotoxicity of vindesine and cis-platinum for human lung tumours by the use of verapamil in vitro.
por: Simmonds, A. P., et al.
Publicado: (1986) -
Small intestinal mucosal toxicity of cis-platinum--comparison of toxicity with platinum analogues and dexamethasone.
por: Allan, S. G., et al.
Publicado: (1986) -
Cystic fluid-platinum kinetics in ovarian cancer patients: relevance to cis-dichlorodiammine platinum (II) sensitivity testing in vitro.
por: Shelley, M. D., et al.
Publicado: (1985)